New balloon treatment for heart disease under Real-World study
NCT ID NCT02038660
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 1,500 people with coronary artery disease who are treated with a drug-eluting balloon during angioplasty. The balloon releases a medicine (paclitaxel) to help keep the artery open. Researchers are checking how well it works and if it is safe over the long term, looking at events like heart attacks or the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
drug-eluting balloon (paclitaxel-coated balloon)
What this could lead to
If successful, this could confirm that drug-eluting balloons are a safe and effective option for treating coronary artery disease, potentially reducing the need for stents.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. The balloon uses paclitaxel, which carries risks like allergic reactions or blood flow issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
Contact Email: •••••@•••••
Contact
-
Chonnam National University Hospital
RECRUITINGGwangju, South Korea
Contact Email: •••••@•••••
Contact
-
Dong-A Medical Center
RECRUITINGPusan, South Korea
Contact Email: •••••@•••••
Contact
-
Gangnam Severance Hospital
RECRUITINGSeoul, South Korea
Contact Email: •••••@•••••
Contact
-
Keimyung University Dongsan Medical Center
RECRUITINGDaegu, South Korea
Contact Email: •••••@•••••
Contact
-
Korea University Guro Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact
Contact
-
Soon Chun Hyang University Hospital Bucheon
TERMINATEDBucheon-si, South Korea
-
The Catholic University of Korea, Daejeon ST. Mary's Hospital
TERMINATEDDaejeon, South Korea
-
Ulsan University Hospital
RECRUITINGUlsan, South Korea
Contact Email: •••••@•••••
Contact